These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 23927413

  • 1. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.
    Bahrami B, Greenwell T, Muecke JS.
    Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413
    [Abstract] [Full Text] [Related]

  • 2. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
    Rudkin AK, Dempster L, Muecke JS.
    Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
    [Abstract] [Full Text] [Related]

  • 3. Treatment of ocular surface squamous neoplasia with Mitomycin C.
    Gupta A, Muecke J.
    Br J Ophthalmol; 2010 May; 94(5):555-8. PubMed ID: 20447963
    [Abstract] [Full Text] [Related]

  • 4. Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.
    Blasi MA, Maceroni M, Sammarco MG, Pagliara MM.
    Eur J Ophthalmol; 2018 Mar; 28(2):204-209. PubMed ID: 28967069
    [Abstract] [Full Text] [Related]

  • 5. The effect of surgical wide excision and amniotic membrane transplantation with adjuvant topical mitomycin C treatment in recurrent conjunctival--corneal intraepithelial neoplasia.
    Lee JH, Kim YH, Kim MS, Kim EC.
    Semin Ophthalmol; 2014 Jul; 29(4):192-5. PubMed ID: 23971714
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
    Besley J, Pappalardo J, Lee GA, Hirst LW, Vincent SJ.
    Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
    [Abstract] [Full Text] [Related]

  • 7. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.
    Zaki AA, Farid SF.
    Cornea; 2009 Oct; 28(9):986-8. PubMed ID: 19724215
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].
    Cartsburg O, Kersten A, Sundmacher R, Nadjari B, Pomjanski N, Böcking A.
    Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009
    [Abstract] [Full Text] [Related]

  • 9. Ocular surface squamous neoplasia: to cut or not to cut.
    Mills RA.
    Clin Exp Ophthalmol; 2014 Jun; 42(4):307-8. PubMed ID: 24890086
    [No Abstract] [Full Text] [Related]

  • 10. Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C.
    Nemet AY, Sharma V, Benger R.
    Clin Exp Ophthalmol; 2006 Jun; 34(4):375-7. PubMed ID: 16764660
    [Abstract] [Full Text] [Related]

  • 11. Treatment of ocular surface squamous cell intraepithelial neoplasia with and without mitomycin C.
    Birkholz ES, Goins KM, Sutphin JE, Kitzmann AS, Wagoner MD.
    Cornea; 2011 Jan; 30(1):37-41. PubMed ID: 20861726
    [Abstract] [Full Text] [Related]

  • 12. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD, Huang AJ.
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [Abstract] [Full Text] [Related]

  • 13. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
    Demirci H, McCormick SA, Finger PT.
    Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
    [Abstract] [Full Text] [Related]

  • 14. Topical chemotherapy for ocular surface squamous neoplasia.
    Nanji AA, Sayyad FE, Karp CL.
    Curr Opin Ophthalmol; 2013 Jul; 24(4):336-42. PubMed ID: 23680759
    [Abstract] [Full Text] [Related]

  • 15. Postoperative topical mitomycin C in conjunctival squamous cell neoplasia.
    Akpek EK, Ertoy D, Kalayci D, Hasiripi H.
    Cornea; 1999 Jan; 18(1):59-62. PubMed ID: 9894938
    [Abstract] [Full Text] [Related]

  • 16. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution.
    Hirst LW.
    Ophthalmology; 2007 May; 114(5):976-82. PubMed ID: 17241666
    [Abstract] [Full Text] [Related]

  • 17. Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia.
    Kusumesh R, Ambastha A, Kumar S, Sinha BP, Imam N.
    Cornea; 2017 Mar; 36(3):327-331. PubMed ID: 28079688
    [Abstract] [Full Text] [Related]

  • 18. Topical medical therapies for ocular surface tumors.
    Poothullil AM, Colby KA.
    Semin Ophthalmol; 2006 Mar; 21(3):161-9. PubMed ID: 16912014
    [Abstract] [Full Text] [Related]

  • 19. Mitomycin C as an adjunct in the treatment of localised ocular surface squamous neoplasia.
    Chen C, Louis D, Dodd T, Muecke J.
    Br J Ophthalmol; 2004 Jan; 88(1):17-8. PubMed ID: 14693762
    [Abstract] [Full Text] [Related]

  • 20. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
    Wilson MW, Hungerford JL, George SM, Madreperla SA.
    Am J Ophthalmol; 1997 Sep; 124(3):303-11. PubMed ID: 9439356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.